Buy & Sell PepsiCo, Inc. (PEP) – PepsiCo, Inc. Price Today
Aura AI Summary
Key Stats
- $207.54BMarket Cap
- Consumer StaplesSector
- -11.98%3M Drawdown
- $249.44BEnterprise Value
- 3.9%Dividend Yield
- 4% Buy | 96% SellTrading Activity
- 105 daysTypical Hold Time
PepsiCo, Inc. (PEP) is currently valued at a market capitalization of $207.54B, with an enterprise value of $249.44B. Over the past 52 weeks, PepsiCo, Inc. has traded between a low of $128.05 and a high of $170.44, highlighting its annual price range. Over the past three months, PepsiCo, Inc. has recorded a drawdown of -11.98%, reflecting recent price volatility. PepsiCo, Inc. offers a dividend yield of 3.9%, with the most recent dividend of $1.42 paid on 06 Mar 26. On average, investors hold PepsiCo, Inc. for approximately 105 days, indicating typical investor behavior on the platform.
About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Most Recent News
First patient dosed in Phase 1b trial of Sapu003, an IV everolimus for advanced mTOR-sensitive tumors
Sapu Nano and Oncotelic have dosed the first patient in a Phase 1b clinical trial of Sapu003, an intravenous formulation of everolimus designed to treat advanced mTOR-sensitive solid tumors such as HR+/HER2- breast cancer and renal cell carcinoma. Th...

NevGold upsizes financing to C$42M, advancing US antimony-gold project with near-term production plans.
NevGold Corp. has increased its brokered private placement financing from C$25 million to over C$42 million due to strong institutional demand. The Vancouver-based junior miner is developing the Limousine Butte gold-antimony project in Nevada, target...

Quantum Cyber secures exclusive drone tech license amid $55B US drone warfare budget boost
Quantum Cyber has secured an exclusive license for BP United's autonomous drone technology, including a sky defense platform capable of over 25 km range and fully autonomous operations. This move positions Quantum Cyber to capitalize on the Trump adm...
